Código da empresaTBXU
Classe de ativosEquity
Gestora do fundoDirexion
DomicílioUS
Taxa de administração0.98%
Fundado em2025-10-01
Índice de referênciaNYSE Biotechnology Top 5 Equal Weight Index - Benchmark TR Gross
TBXU was created on 2025-10-01 by Direxion. The fund's investment portfolio concentrates primarily on health care equity. TBXUis passively managed, providing 2x leveraged exposure to an equally-weighted index of the top 5 largest US companies in thebiotechnologysub-industry.